Impact of cyclosporine versus tacrolimus on the incidence ofde novomalignancy following liver transplantation: a single center experience with 609 patients

Burden of de novo malignancy in the liver transplant recipient

(2012) Natasha Chandok et al.   LIVER TRANSPLANTATION

Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36 months after transplantation

(2012) Markus Guba et al.   TRANSPLANT INTERNATIONAL

Temporary intraoperative porto-caval shunt: useless or beneficial in piggy back liver transplantation?

(2012) Sebastian Pratschke et al.   TRANSPLANT INTERNATIONAL

Posttransplant Malignancies in Solid Organ Adult Recipients

(2012) Marcelo Santos Sampaio et al.   TRANSPLANTATION

Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit

(2010) D. Collett et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study

(2010) K. D. S. Watt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

(2010) Andreas A Schnitzbauer et al.   BMC CANCER

Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review

(2010) Eric Chak et al.   LIVER INTERNATIONAL

De novo malignancies following liver transplantation: Impact and recommendations

(2010) J. Ignacio Herrero   LIVER TRANSPLANTATION

Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: An association with C2 monitoring and recipient age

(2010) Angela S. W. Tjon et al.   LIVER TRANSPLANTATION

mTOR inhibition: the learning curve in kidney transplantation

(2010) Matthew R. Weir et al.   TRANSPLANT INTERNATIONAL

Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation

(2009) Kymberly D.S. Watt et al.   GASTROENTEROLOGY

Signaling defects in anti-tumor T cells

(2008) Alan B. Frey et al.   IMMUNOLOGICAL REVIEWS

Improving the outcome of liver transplantation with very old donors with updated selection and management criteria

(2008) Matteo Cescon et al.   LIVER TRANSPLANTATION